Global Yellow Nail Syndrome Treatment Market, By Treatment (Genetic Counseling, Surgery, Antibiotic, Corticosteroids, Vitamin E, Zinc supplement, Antifungals), Dosage (Tablet, Injection, Cream, Capsule, Others), Route of Administration (Topical, Parenteral, Intramuscular, Intravenous, Oral), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Yellow Nail Syndrome Treatment Market
Global yellow nail syndrome treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6% in the above mentioned forecast period.
Yellow nail syndrome (YNS) is a rare dermatological disorder which is characterised by the presence of two of the following: slow-growing, hard, yellow, and dystrophic nails; lymphedema and respiratory tract disease. The cause of this condition is unknown but sometimes it is associated with autoimmune disease, lymphatic diseases or cancer. YNS mainly affects the fingernails, toenails, respiratory tract, and gravity-dependent areas that can accumulate fluid. This syndrome is acquired and mainly affects adults with over age 50. However it is also observed in children and new born.
Rise in the prevalence of disease, increasing geriatric population, growing government initiatives, advancement in treatment options, genetic counselling, and rising awareness are the factors that will expand the global yellow nail syndrome treatment market.
Rising R&D activities and growing focus of major pharmaceutical companies towards novel treatment therapies will provide beneficial opportunities for the global yellow nail syndrome treatment market in the forecast period of 2021-2028.
Life threatening complications are observed in yellow nail syndrome related to pulmonary and lymphatic manifestations. No cure for yellow nail syndrome as the treatment is aimed at improving symptoms, and high cost of treatment are the factors that will hamper the market growth and will further challenge the global yellow nail syndrome treatment market in the forecast period mentioned above.
\This yellow nail syndrome treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global yellow nail syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Yellow Nail Syndrome Treatment Market Scope and Market Size
The yellow nail syndrome treatment market is segmented on the basis of treatment, dosage, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the yellow nail syndrome treatment market is segmented into genetic counseling, surgery, antibiotic, corticosteroids, vitamin E, zinc supplement, and antifungals. Corticosteroids have been further sub-segmented into intralesional triamcinolone. Vitamin E has been further sub-segmented into α-tocopheryl acetate. Antifungals have been further sub-segmented into itraconazole and fluconazole.
- On the basis of dosage, the yellow nail syndrome treatment market is segmented into tablet, injection, cream, capsule, and others.
- On the basis of route of administration, the yellow nail syndrome treatment market is segmented into topical, parenteral, intramuscular, intravenous and oral.
- On the basis of end-users, the yellow nail syndrome treatment market is segmented into clinic, hospital and others.
- The yellow nail syndrome treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy.
Global Yellow Nail Syndrome Treatment Market Country Level Analysis
Global yellow nail syndrome treatment market is analyzed, and market size information is provided by the country, treatment, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the global yellow nail syndrome treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the yellow nail syndrome treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease, and increasing awareness towards health in this region. Global yellow nail syndrome treatment market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global yellow nail syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Yellow Nail Syndrome Treatment Market Share Analysis
Global yellow nail syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global yellow nail syndrome treatment market.
The major players covered in the global yellow nail syndrome treatment market report are Novartis AG, Sanofi, Pfizer Inc., Sumitomo Corporation, Johnson & Johnson Private Limited, AstraZeneca, Cipla Inc., Abbott, Bayer AG, Merck KGaA, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Allergan, Merck Sharp & Dohme Corp., Mylan N.V., Teva Pharmaceutical Industries Ltd., and Enzon Pharmaceuticals, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-